PERTH, WA and GREER, SC--(Marketwired - Aug 26, 2015) - Alexium International Group Limited (Alexium) (
As previously noted, as product testing progresses, this Customer continues to see an increasing range of opportunity of Alexiflam™ treatments on their home furnishing products. This has resulted in multiple production runs and an increase in purchase orders preparing for a larger than initially expected full commercial ramp-up. The initial product roll-out has also been increased by the Customer and remains on target for 3rd and 4th quarter revenues.
Steve Gravlee, VP of Sales, stated, "This is further validation that this major US home furnishings and bedding Customer sees the value proposition that our award winning environmentally friendly Alexiflam™ FR treatments bring to their business as they continue testing additional uses of our Alexiflam™ formulations."
Nicholas Clark, CEO, stated, "It is very encouraging to see a continued commitment from this customer to expand our formulations to other product lines. This further cements Alexium as a key partner for this Customer." Mr. Clark added, "We continue to see purchase orders from other commercial sector clients, as well as continuing with our ongoing relationship with the US Department of Defense which shows the value and performance of our treatments in the market place."
About Alexium
Alexium International Group Limited (ASX: AJX, AX:AJX OTC QX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatment are currently marketed for different fabric markets under the Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.
Contact Information:
U.S Contacts:
Nick Clark
Chief Executive Officer
nclark@alexiuminternational.com
U.S.: +1 864.991.6687
Bradi Dobson
Marketing Specialist
BDobson@alexiuminternational.com
U.S. R&D Center:
8 Distribution Court
Greer, SC 29650
T: +1 864.416.1060
F: +1 864.752.6465
U.S. Corporate Office:
148 Milestone Way
Greenville, SC 29615
T: +1 864.603.1165
F: +1 864.752.6465
Australia:
Matt Wright
Investor Relations
matt@nwrcommunications.com.au
AUS: +61 451.896.420
ABN: 91 064 820 408
ASX: AJX